Literature DB >> 28737134

WITHDRAWN: Nephrotic syndrome in primary myelofibrosis with renal extramedullary hematopoiesis and glomerulopathy in the JAK inhibitor era.

Rachele Del Sordo, Rachele Brugnano, Carla Covarelli, Gioia Fiorucci, Franca Falzetti, Giorgio Barbatelli, Emidio Nunzi, Angelo Sidoni.   

Abstract

Ahead of Print article withdrawn by publisher. The publisher apologizes for any inconvenience this has caused. The article was scheduled for the journal "Clinical Nephrology. Case Studies" (issn 2196-5293). The article is available in PubmedCentral: https://www.ncbi.nlm.nih.gov/pubmed/29350220 .

Entities:  

Year:  2017        PMID： 28737134     DOI： 10.5414/CNCS109100

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN： 0301-0430            Impact factor:   0.975


  16 in total

1.  Renal myelofibrosis: an unusual cause of renal impairment.

Authors:  N Woodward; P Ancliffe; M H Griffiths; S Cohen
Journal:  Nephrol Dial Transplant       Date:  2000-02       Impact factor: 5.992

2.  Idiopathic myelofibrosis with extramedullary hematopoiesis in the kidneys.

Authors:  P Schnuelle; R Waldherr; K J Lehmann; J Woenckhaus; W Back; Z Niemir; F J van der Woude
Journal:  Clin Nephrol       Date:  1999-10       Impact factor: 0.975

3.  Nephrotic syndrome associated with agnogenic myeloid metaplasia.

Authors:  Omer Nuri Pamuk; Gülsüm Emel Pamuk; Mehmet Riza Altiparmak; Abdullah Sonsuz; Seyhun Solakoğlu; Isin Kiliçaslan
Journal:  Leuk Lymphoma       Date:  2002-03

4.  Myeloproliferative neoplasms cause glomerulopathy.

Authors:  Samar M Said; Nelson Leung; Sanjeev Sethi; Lynn D Cornell; Mary E Fidler; Joseph P Grande; Sandra Herrmann; Ayalew Tefferi; Vivette D D'Agati; Samih H Nasr
Journal:  Kidney Int       Date:  2011-06-08       Impact factor: 10.612

5.  [Glomerular disease associated with myelofibrosis (author's transl)].

Authors:  Y Caijo; C Almange; J Boutin; P Y Le Prise; D Guérin
Journal:  Sem Hop       Date:  1979 Mar 8-15

6.  Nephrotic syndrome associated with agnogenic myeloid metaplasia.

Authors:  M A Perazella; G K Buller
Journal:  Am J Nephrol       Date:  1994       Impact factor: 3.754

7.  Renal extramedullary hematopoiesis: interstitial and glomerular pathology.

Authors:  Mariam P Alexander; Samih H Nasr; Paul J Kurtin; Edward T Casey; Loren P Herrera Hernandez; Mary E Fidler; Sanjeev Sethi; Lynn D Cornell
Journal:  Mod Pathol       Date:  2015-10-09       Impact factor: 7.842

8.  Nonhepatosplenic extramedullary hematopoiesis: associated diseases, pathology, clinical course, and treatment.

Authors:  Cody A Koch; Chin-Yang Li; Ruben A Mesa; Ayalew Tefferi
Journal:  Mayo Clin Proc       Date:  2003-10       Impact factor: 7.616

9.  Myelofibrosis-associated complications: pathogenesis, clinical manifestations, and effects on outcomes.

Authors:  Tariq I Mughal; Kris Vaddi; Nicholas J Sarlis; Srdan Verstovsek
Journal:  Int J Gen Med       Date:  2014-01-29

10.  Primary myelofibrosis associated glomerulopathy: significant improvement after therapy with ruxolitinib.

Authors:  Arun Rajasekaran; Thuy-Trang Ngo; Maen Abdelrahim; William Glass; Amber Podoll; Srdan Verstovsek; Ala Abudayyeh
Journal:  BMC Nephrol       Date:  2015-08-01       Impact factor: 2.388
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.